About KCJ

Kidney Cancer Journal is a quarterly peer-reviewed cancer journal reaching more than 12,500 oncology and urology clinicians. Kidney Cancer Journal is the official Journal of the Kidney Cancer Association. The objective of KCJ is to serve as the most comprehensive, peer-reviewed resource of information for physicians on the diagnosis and treatment of renal cell carcinoma and its tumor types. KCJ supports the mission of the Kidney Caner Association by facilitating the knowledge transfer, contributing to cancer prevention, early detection, diagnosis, and cure of kidney cancer. KCJ publishes original articles, reviews, clinical case studies as well as letters to the editor. KCJ provides editorial content encompassing a wide array of topics relevant and useful to the fields of oncology and journal contents are directed by the potential insights of today’s Key Opinion Leaders in oncology around the world.

Kidney Cancer Journal is the only peer-reviewed medical journal and most comprehensive source of scientific information focusing exclusively on renal cell carcinoma. In addition, special reports and supplements covering ASCO meeting and highlights from the annual International Kidney Cancer Association Meeting also published. KCJ is distributed as a complimentary professional service to approximately 12,300 physicians, including all medical oncologists and targeted urologists. KCJ utilizes a Medical Advisory Board and Editorial Advisory Board of more than 30 oncologists/physicians who are leading investigators in this field. Archives available through the KCJ website here and also KCA’s website at www.kidneycancer.org

EDITORIAL BOARD

Editor-in-Chief

Robert A. Figlin, MD, FACP

Steven Spielberg Family Chair in Hematology Oncology Professor of Medicine and Biomedical Sciences Director, Division of Hematology Oncology Deputy Director, Samuel Oschin Comprehensive Cancer Institute Cedars-Sinai Medical Center Los Angeles, California


Medical Advisory Board

Michael B. Atkins, MD

Deputy Chief, Division of Hematology-Oncology Director, Cancer Clinical Trials Office Beth Israel Deaconess Medical Center Leader, Renal Cancer Program, Dana Farber Harvard Cancer Center Boston, Massachusetts

Ronald M. Bukowski, MD

Director, Department of Experimental Therapeutics Cleveland Clinic Taussig Cancer Center Cleveland, Ohio

Christopher G. Wood, MD

Associate Professor, Departments of Urology and Cancer Biology University of Texas M.D. Anderson Cancer Center Houston, Texas

Robert J. Motzer, MD

Attending Physician, Memorial Sloan-Kettering Cancer Center New York City Professor of Medicine Weill Medical College of Cornell University Ithaca, New York

Walter M. Stadler, MD

Fred C. Buffett Professor Departments of Medicine and Surgery Sections of Hematology-Oncology and Urology University of Chicago Medical Center Chicago, Illinois


Nurse Advisory Board

Nancy Moldawer, RN, MSN

Nursing Director City of Hope Kidney Cancer Program City of Hope Comprehensive Cancer Center Duarte, California

Laura Wood, RN, MSN, OCN

Renal Cancer Research Coordinator Cleveland Clinic Taussig Cancer Center Cleveland, Ohio


Patient Advocate

Gretchen E. Vaughan

Chief Executive Officer Kidney Cancer Association


Publishing Staff

  • Senthil Samy, PhD.,Executive Editors
  • Vinu Jyothi, MD, MPH., Assoc. Director, Editorial Services
  • Stu Chapman,Editorial Consultant
  • Susan Hirschhaut,Director of Advertising and Strategic Initiatives
  • Michael McClain,Design Director

Editorial Offices

517 Belle Gate Pl Cary NC 27519

Copyright 2020 BioMedz Global LLC All rights reserved. None of the contents may be reproduced in any form without the permission of the publisher.


Editorial Advisory Board

Arie Belldegrun, MD

David Geffen School of Medicine at UCLA Los Angeles, California

Steven Campbell, MD

Cleveland Clinic Foundation Cleveland, Ohio

Janice P. Dutcher, MD

Our Lady of Mercy Medical Center Comprehensive Cancer Center Bronx, New York

Timothy Eisen, MD

Royal Marsden Hospital London, UK

Paul Elson, PhD

Cleveland Clinic Foundation Cleveland, Ohio

Bernard Escudier, MD

Institut Gustave-Roussy Villejuif, France

James H. Finke, PhD

Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Cleveland, Ohio

Keith Flaherty, MD

Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania

Daniel J. George, MD

Duke Clinical Research Institute Durham, North Carolina

Martin Gore, MD

Royal Marsden Hospital London, UK

Gary Hudes, MD

Fox Chase Cancer Center Philadelphia, Pennsylvania

Thomas Hutson, DO, PharmD

Baylor University Medical Center Dallas, Texas

Eric Jonasch, MD

University of Texas MD Anderson Cancer Center Houston, Texas

Eugene D. Kwon, MD

Mayo Clinic Rochester, Minnesota

Bradley C. Leibovich, MD

Mayo Clinic Rochester, Minnesota

Kim A. Margolin, MD

City of Hope National Medical Center Duarte, California

David Nanus, MD

New York Presbyterian Hospital- Weill Cornell Medical Center New York, New York

Andrew C. Novick, MD

Cleveland Clinic Foundation Cleveland, Ohio

Leslie Oleksowicz, MD

College of Medicine University of Cincinnati Medical Center Cincinnati, Ohio

Allan Pantuck, MD

David Geffen School of Medicine at UCLA Los Angeles, California

Brian Rini, MD

Vanderbilt-Ingram Cancer Center Vanderbilt University Medical Center Nashville, Tennessee

Paul Russo, MD

Memorial Sloan-Kettering Cancer Center New York, New York

Ihor S. Saczuk, MD

Hackensack University Medical Center Hackensack, New Jersey

Domenic A. Sica, MD

Medical College of Virginia Richmond, Virginia

Jeffrey A. Sosman, MD

Vanderbilt University Medical Center Vanderbilt-Ingram Cancer Center Nashville, Tennessee

David Swanson, MD

University of Texas MD Anderson Cancer Center Houston, Texas

Nicholas J. Vogelzang, MD

Nevada Cancer Institute Las Vegas, Nevada